OBJECTIVE: Due to shortages of N95 respirators during the coronavirus disease 2019 (COVID-19) pandemic, it is necessary to estimate the number of N95s required for healthcare workers (HCWs) to inform manufacturing targets and resource allocation. METHODS: We developed a model to determine the number of N95 respirators needed for HCWs both in a single acute-care hospital and the United States. RESULTS: For an acute-care hospital with 400 all-cause monthly admissions, the number of N95 respirators needed to manage COVID-19 patients admitted during a month ranges from 113 (95% interpercentile range [IPR], 50-229) if 0.5% of admissions are COVID-19 patients to 22,101 (95% IPR, 5,904-25,881) if 100% of admissions are COVID-19 patients (assuming single use per respirator, and 10 encounters between HCWs and each COVID-19 patient per day). The number of N95s needed decreases to a range of 22 (95% IPR, 10-43) to 4,445 (95% IPR, 1,975-8,684) if each N95 is used for 5 patient encounters. Varying monthly all-cause admissions to 2,000 requires 6,645-13,404 respirators with a 60% COVID-19 admission prevalence, 10 HCW-patient encounters, and reusing N95s 5-10 times. Nationally, the number of N95 respirators needed over the course of the pandemic ranges from 86 million (95% IPR, 37.1-200.6 million) to 1.6 billion (95% IPR, 0.7-3.6 billion) as 5%-90% of the population is exposed (single-use). This number ranges from 17.4 million (95% IPR, 7.3-41 million) to 312.3 million (95% IPR, 131.5-737.3 million) using each respirator for 5 encounters. CONCLUSIONS: We quantified the number of N95 respirators needed for a given acute-care hospital and nationally during the COVID-19 pandemic under varying conditions.
OBJECTIVE: Due to shortages of N95 respirators during the coronavirus disease 2019 (COVID-19) pandemic, it is necessary to estimate the number of N95s required for healthcare workers (HCWs) to inform manufacturing targets and resource allocation. METHODS: We developed a model to determine the number of N95 respirators needed for HCWs both in a single acute-care hospital and the United States. RESULTS: For an acute-care hospital with 400 all-cause monthly admissions, the number of N95 respirators needed to manage COVID-19patients admitted during a month ranges from 113 (95% interpercentile range [IPR], 50-229) if 0.5% of admissions are COVID-19patients to 22,101 (95% IPR, 5,904-25,881) if 100% of admissions are COVID-19patients (assuming single use per respirator, and 10 encounters between HCWs and each COVID-19patient per day). The number of N95s needed decreases to a range of 22 (95% IPR, 10-43) to 4,445 (95% IPR, 1,975-8,684) if each N95 is used for 5 patient encounters. Varying monthly all-cause admissions to 2,000 requires 6,645-13,404 respirators with a 60% COVID-19 admission prevalence, 10 HCW-patient encounters, and reusing N95s 5-10 times. Nationally, the number of N95 respirators needed over the course of the pandemic ranges from 86 million (95% IPR, 37.1-200.6 million) to 1.6 billion (95% IPR, 0.7-3.6 billion) as 5%-90% of the population is exposed (single-use). This number ranges from 17.4 million (95% IPR, 7.3-41 million) to 312.3 million (95% IPR, 131.5-737.3 million) using each respirator for 5 encounters. CONCLUSIONS: We quantified the number of N95 respirators needed for a given acute-care hospital and nationally during the COVID-19 pandemic under varying conditions.
Authors: Sarah M Bartsch; Marie C Ferguson; James A McKinnell; Kelly J O'Shea; Patrick T Wedlock; Sheryl S Siegmund; Bruce Y Lee Journal: Health Aff (Millwood) Date: 2020-04-23 Impact factor: 6.301
Authors: Noelle-Angelique M Molinari; Ismael R Ortega-Sanchez; Mark L Messonnier; William W Thompson; Pascale M Wortley; Eric Weintraub; Carolyn B Bridges Journal: Vaccine Date: 2007-04-20 Impact factor: 3.641
Authors: Matt Arentz; Eric Yim; Lindy Klaff; Sharukh Lokhandwala; Francis X Riedo; Maria Chong; Melissa Lee Journal: JAMA Date: 2020-04-28 Impact factor: 56.272
Authors: Joseph A Lewnard; Vincent X Liu; Michael L Jackson; Mark A Schmidt; Britta L Jewell; Jean P Flores; Chris Jentz; Graham R Northrup; Ayesha Mahmud; Arthur L Reingold; Maya Petersen; Nicholas P Jewell; Scott Young; Jim Bellows Journal: BMJ Date: 2020-05-22
Authors: Z Imam; F Odish; I Gill; D O'Connor; J Armstrong; A Vanood; O Ibironke; A Hanna; A Ranski; A Halalau Journal: J Intern Med Date: 2020-06-22 Impact factor: 13.068
Authors: Sara C Auld; Mark Caridi-Scheible; James M Blum; Chad Robichaux; Colleen Kraft; Jesse T Jacob; Craig S Jabaley; David Carpenter; Roberta Kaplow; Alfonso C Hernandez-Romieu; Max W Adelman; Greg S Martin; Craig M Coopersmith; David J Murphy Journal: Crit Care Med Date: 2020-09 Impact factor: 9.296
Authors: Sarah M Bartsch; Kelly J O'Shea; Marie C Ferguson; Maria Elena Bottazzi; Patrick T Wedlock; Ulrich Strych; James A McKinnell; Sheryl S Siegmund; Sarah N Cox; Peter J Hotez; Bruce Y Lee Journal: Am J Prev Med Date: 2020-07-15 Impact factor: 5.043
Authors: Jeremy A W Gold; Karen K Wong; Christine M Szablewski; Priti R Patel; John Rossow; Juliana da Silva; Pavithra Natarajan; Sapna Bamrah Morris; Robyn Neblett Fanfair; Jessica Rogers-Brown; Beau B Bruce; Sean D Browning; Alfonso C Hernandez-Romieu; Nathan W Furukawa; Mohleen Kang; Mary E Evans; Nadine Oosmanally; Melissa Tobin-D'Angelo; Cherie Drenzek; David J Murphy; Julie Hollberg; James M Blum; Robert Jansen; David W Wright; William M Sewell; Jack D Owens; Benjamin Lefkove; Frank W Brown; Deron C Burton; Timothy M Uyeki; Stephanie R Bialek; Brendan R Jackson Journal: MMWR Morb Mortal Wkly Rep Date: 2020-05-08 Impact factor: 17.586
Authors: Ethan D Fechter-Leggett; Kathleen B Fedan; Jean M Cox-Ganser; Martin I Meltzer; Bishwa B Adhikari; Chad H Dowell Journal: Health Secur Date: 2022-02-01
Authors: Sarah M Bartsch; Kelly J O'Shea; Kevin L Chin; Ulrich Strych; Marie C Ferguson; Maria Elena Bottazzi; Patrick T Wedlock; Sarah N Cox; Sheryl S Siegmund; Peter J Hotez; Bruce Y Lee Journal: Lancet Public Health Date: 2022-03-08